LBH589 in Refractory Myelodysplastic Syndromes (MDS)

计划入组 26 人 · 首次发布于 2008 年 1 月 15 日

The National Myelodysplastic Syndromes (MDS) Study

计划入组 2,115 人 · 首次发布于 2016 年 5 月 17 日

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

计划入组 99 人 · 首次发布于 2007 年 3 月 6 日

Decitabine(Dacogen, Inqovi 5 Tablet Pack, Inaqovi)

C₈H₁₂N₄O₄ · Rx

MDS-11P

EXG-MDS

Nordic MDS Group

Sweden

De Cardenas & Villalonga MDS, PA

United States

Aplastic Anemia And Mds International Foundation Inc

United States

Luspatercept Demonstrates Sustained Transfusion Independence in Myelodysplastic Syndromes

Luspatercept Demonstrates Significant Reduction in Transfusion Burden in Lower-Risk MDS Patients: COMMANDS Trial

Taiho Oncology Announces Publication of Final Results from ASCERTAIN Clinical Trial